Akèy › Myelom Miltip › Oregon › Eugene
Etid klinik pou Myelom Miltip nan Eugene, OR
6 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- Willamette Valley Cancer Institute and Research Center, Eugene
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Ap rekriteFaz 2/3
- Willamette Valley Cancer Institute and Research Center /ID# 278721, Eugene
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
Ap rekriteFaz 2
- Willamette Valley Cancer Institute and Research Center, Eugene
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Ap rekriteFaz 2
- Oncology Associates of Oregon, Eugene
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Ap rekriteFaz 1/2
- Oncology Associates of Oregon, Eugene
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Eugene
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè9 etid
- Kansè Endomèt8 etid
- Kansè nan tete7 etid
- Lukemi lenfositè kwonik6 etid
- Kansè Metastatik6 etid
- Kansè (tout kalite)6 etid
- Itilizasyon Dwòg ak Depandans5 etid
- Kansè poumon5 etid
- Degeneresans makile5 etid
- Obèsite4 etid
- Kansè pwostat3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.